Why positive pressure ventilation in chronic heart failure? Source: Annual Congress 2008 - Noninvasive positive pressure in heart failure - where are we now with two large multicentre studies showing no apparent benefit? Year: 2008
Noninvasive positive pressure ventilation in acute respiratory failure: clinical outcome and correlates for success and failure Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement Year: 2008
Can continuous positive airway pressure influence the progression of ischemic heart disease? Source: 5th Sleep and Breathing Conference Year: 2019
Why positive pressure ventilation in acute heart failure? Source: Annual Congress 2008 - Noninvasive positive pressure in heart failure - where are we now with two large multicentre studies showing no apparent benefit? Year: 2008
The effects of noninvasive positive pressure ventilation on exercise tolerance in hospitalized patients with decompensated heart failure: A randomised cross-over trial Source: International Congress 2015 – Physical activity, exercise and rehabilitation in COPD and beyond Year: 2015
The clear evidence for pulmonary rehabilitation in chronic lung disease - a review of the most important randomised controlled trials Source: International Congress 2018 – PG14 The evolving world of pulmonary rehabilitation Year: 2018
Noninvasive positive pressure ventilation in patients with acute respiratory failure: factors associated with failure or success Source: Eur Respir J 2001; 18: Suppl. 33, 30s Year: 2001
LATE-BREAKING ABSTRACT: Clinical profile, outcomes, and ivabradine effects in patients with chronic obstructive pulmonary disease and chronic heart failure: the SHIFT trial analysis Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013
Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value Source: Eur Respir J 2007; 29: 432-434 Year: 2007
Effect of noninvasive ventilation on thoracoabdominal kinematics in patients with heart failure associated to cardiomegaly: A controlled randomized clinical trial Source: International Congress 2014 – Clinical physiology and respiratory muscles Year: 2014
Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease Source: International Congress 2014 – Markers Year: 2014
A randomised control trial of pulmonary rehabilitation for patients with chronic heart failure Source: Annual Congress 2007 - Assessment and outcomes in non-COPD patients Year: 2007
Optimising pharmacotherapy in patients with pulmonary arterial hypertension and comorbidities, including lung diseases and heart failure: benefits without harm? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018
Do we need controlled clinical trials in pulmonary arterial hypertension? Source: Eur Respir J 2001; 17: 1-3 Year: 2001
Nonlinear dynamics of heart rate variability in patients with chronic obstructive pulmonary disease and changes after 4-week rehabilitation Source: International Congress 2014 – Clinical physiology and respiratory muscles Year: 2014
Does heart failure make a difference in pulmonary function testing? Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020
Sleep, work of breathing and effect of continuous positive airway pressure in children with chronic heart failure Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment Year: 2020
Clinical impact and prognostic value of mouth occlusion pressure in patients with chronic ventilatory failure Source: Eur Respir J 2007; 30: Suppl. 51, 522s Year: 2007
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009